Optimization of Photon-Counting CT Myelography for the Detection of CSF-Venous Fistulas Using Convolutional Neural Network Denoising: A Comparative Analysis of Reconstruction Techniques
Abstract
BACKGROUND AND PURPOSE: Photon-counting detector CT myelography (PCD-CTM) is a recently described technique used for detecting spinal CSF leaks, including CSF-venous fistulas. Various image reconstruction techniques, including smoother-versus-sharper kernels and virtual monoenergetic images, are available with photon-counting CT. Moreover, denoising algorithms have shown promise in improving sharp kernel images. No prior studies have compared image quality of these different reconstructions on photon-counting CT myelography. Here, we sought to compare several image reconstructions using various parameters important for the detection of CSF-venous fistulas.
MATERIALS AND METHODS: We performed a retrospective review of all consecutive decubitus PCD-CTM between February 1, 2022, and August 1, 2024, at 1 institution. We included patients whose studies had the following reconstructions: Br48-40 keV virtual monoenergetic reconstruction, Br56 low-energy threshold (T3D), Qr89-T3D denoised with quantum iterative reconstruction, and Qr89-T3D denoised with a convolutional neural network algorithm. We excluded patients who had extradural CSF on preprocedural imaging or a technically unsatisfactory myelogram-. All 4 reconstructions were independently reviewed by 2 neuroradiologists. Each reviewer rated spatial resolution, noise, the presence of artifacts, image quality, and diagnostic confidence (whether positive or negative) on a 1-5 scale. These metrics were compared using the Friedman…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.